Contact:
4008465777
-
About Us
News & Events
-
01-26
Tonghua Dongbao’s strategic partner Adocia reports positive clinical trial results for BC Lispro
On January 26 (Beijing time), Adocia, a biotechnology company focused on the treatment of diabetes and other metabolic diseases, announced positive results of its clinical trial of the ultra-rapid-acting insulin lispro...
-
01-21
Tonghua Dongbao plans to set up novel drug R&D center in Hangzhou
On the evening of January 21, Tonghua Dongbao Pharmaceutical Co., Ltd. (stock code: 600867, hereinafter referred to as "Tonghua Dongbao" or the "Company") announced that the Company plans to invest RMB...
-
01-14
Tonghua Dongbao reports annual net profit of RMB 929 million for 2020
On the evening of January 14, 2021, Tonghua Dongbao (600867) released a performance report which disclosed that the Company achieved operating revenue of RMB 2.925 billion, up 5.32% YoY, and a net profit attributable...
-
02-21
Tonghua Dongbao donates RMB 22 million worth of medicines and RMB 1 million in cash to help curb pandemic in Tonghua
While taking active measures to resume operations during the pandemic, Tonghua Dongbao donated RMB 22 million worth of medicines and RMB 1 million in cash to the Tonghua Red Cross Society to support...